Expert Interview
Discussing Jasper Therapeutics’ Updated Briquilimab Data in Chronic Spontaneous Urticaria
Ticker(s): JSPRInstitution: Allergy and Clinical Immunology Specialists
- Board-certified allergist and immunologist with hospital affiliations including St. Clair Hospital and UPMC Mercy Hospital.
Manages 250+ patients with CSU and other conditions such as immunodeficiency syndromes, allergic rhinitis, and food and environmental allergies, often incorporating skin testing, desensitization, and tailored immunotherapy.
Principal or sub-investigator in multiple CSU clinical trials and contributed to peer-reviewed publications in immunology and allergy
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
